house · trading 2014-12-03 → 2026-06-30
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
By recent-buy return, Virginia Foxx ranks #83 of 122 lawmakers — in the bottom 68%.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2021-12-13 | XOM | BUY | $1K–$15K | $61.63 | $156.44 2026-08-27 | +153.8% |
| 2021-11-30 | PBA | BUY | $1K–$15K | $29.65 | $48.39 2026-08-27 | +63.2% |
| 2021-11-26 | PAA | BUY | $15K–$50K | $9.90 | $25.51 2026-08-27 | +157.7% |
| 2021-11-26 | BXMT | BUY | $15K–$50K | $30.90 | $13.81 2026-08-27 | -55.3% |
| 2021-11-23 | PM | BUY | $1K–$15K | $89.65 | $190.48 2026-08-27 | +112.5% |
| 2021-11-19 | ILPT | BUY | $1K–$15K | $23.26 | $8.32 2026-08-27 | -64.2% |
| 2021-11-19 | EPD | BUY | $1K–$15K | $21.70 | $39.05 2026-08-27 | +80.0% |
| 2021-11-15 | PAA | BUY | $1K–$15K | $10.59 | $25.51 2026-08-27 | +140.9% |
| 2021-11-15 | EPD | BUY | $1K–$15K | $22.92 | $39.05 2026-08-27 | +70.4% |
| 2021-11-11 | AM | BUY | $1K–$15K | $10.80 | $22.53 2026-08-27 | +108.6% |
| 2021-11-08 | NHI | BUY | $1K–$15K | $54.40 | $72.56 2026-08-27 | +33.4% |
| 2021-11-04 | T | BUY | $1K–$15K | $18.73 | $25.43 2026-08-27 | +35.8% |
| 2021-11-02 | T | BUY | $1K–$15K | $19.06 | $25.43 2026-08-27 | +33.5% |
| 2021-10-26 | SCU | BUY | $1K–$15K | — | — | — |
| 2021-10-25 | SCU | BUY | $15K–$50K | — | — | — |
| 2021-10-13 | MO | BUY | $1K–$15K | $47.92 | $67.67 2026-08-27 | +41.2% |
| 2021-10-08 | VIASP | BUY | $1K–$15K | $25.45 | $25.62 2026-07-09 | +0.7% |
| 2021-10-08 | GSK | BUY | $1K–$15K | $38.71 | $50.27 2026-08-27 | +29.9% |
| 2021-10-07 | OLP | BUY | $1K–$15K | $31.57 | $24.13 2026-08-27 | -23.6% |
| 2021-10-07 | DUKH | SELL | $50K–$100K | — | — | — exit |
| 2021-10-04 | PPL | BUY | $1K–$15K | $28.29 | $34.44 2026-08-27 | +21.7% |
| 2021-09-28 | PM | BUY | $15K–$50K | $98.42 | $190.48 2026-08-27 | +93.5% |
| 2021-09-27 | BP | BUY | $1K–$15K | $27.08 | $42.34 2026-08-27 | +56.4% |
| 2021-09-13 | XOM | BUY | $1K–$15K | $55.37 | $156.44 2026-08-27 | +182.5% |
| 2021-09-10 | ILPT | BUY | $15K–$50K | $26.18 | $8.32 2026-08-27 | -68.2% |
| 2021-08-16 | PAA | BUY | $1K–$15K | $9.73 | $25.51 2026-08-27 | +162.2% |
| 2021-08-13 | EPD | BUY | $1K–$15K | $22.52 | $39.05 2026-08-27 | +73.4% |
| 2021-08-11 | AM | BUY | $1K–$15K | $9.35 | $22.53 2026-08-27 | +141.0% |
| 2021-08-09 | XOM | BUY | $50K–$100K | $57.20 | $156.44 2026-08-27 | +173.5% |
| 2021-08-09 | PBA | BUY | $15K–$50K | $31.68 | $48.39 2026-08-27 | +52.8% |
| 2021-08-09 | NHI | BUY | $1K–$15K | $65.44 | $72.56 2026-08-27 | +10.9% |
| 2021-08-09 | BXMT | BUY | $50K–$100K | $31.96 | $13.81 2026-08-27 | -56.8% |
| 2021-08-06 | NHI | BUY | $1K–$15K | $66.63 | $72.56 2026-08-27 | +8.9% |
| 2021-08-03 | T | BUY | $1K–$15K | $21.29 | $25.43 2026-08-27 | +19.4% |
| 2021-07-12 | OLP | BUY | $1K–$15K | $29.57 | $24.13 2026-08-27 | -18.4% |
| 2021-07-12 | MO | BUY | $1K–$15K | $47.49 | $67.67 2026-08-27 | +42.5% |
| 2021-07-09 | GSK | BUY | $1K–$15K | $40.16 | $50.27 2026-08-27 | +25.2% |
| 2021-07-01 | PPL | BUY | $1K–$15K | $28.26 | $34.44 2026-08-27 | +21.9% |
| 2021-06-21 | BP | BUY | $1K–$15K | $26.94 | $42.34 2026-08-27 | +57.2% |
| 2021-05-27 | TPCO | SELL | $15K–$50K | — | — | — exit |
| 2021-05-27 | NHI | BUY | $15K–$50K | $65.56 | $72.56 2026-08-27 | +10.7% |
| 2021-05-17 | PAA | BUY | $1K–$15K | $10.45 | $25.51 2026-08-27 | +144.1% |
| 2021-05-13 | EPD | BUY | $1K–$15K | $23.61 | $39.05 2026-08-27 | +65.4% |
| 2021-05-13 | AM | BUY | $1K–$15K | $9.22 | $22.53 2026-08-27 | +144.4% |
| 2021-05-12 | NHI | BUY | $15K–$50K | $65.65 | $72.56 2026-08-27 | +10.5% |
| 2021-05-04 | T | BUY | $1K–$15K | $24.18 | $25.43 2026-08-27 | +5.2% |
| 2021-05-03 | MO | BUY | $1K–$15K | $48.37 | $67.67 2026-08-27 | +39.9% |
| 2021-04-19 | NHI | BUY | $50K–$100K | $73.27 | $72.56 2026-08-27 | -1.0% |
| 2021-04-13 | T | BUY | $1K–$15K | $22.38 | $25.43 2026-08-27 | +13.6% |
| 2021-04-09 | GSK | BUY | $1K–$15K | $36.65 | $50.27 2026-08-27 | +37.2% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Alan Armstrong | 41 · CI, PEP, ABT, FDX, GLW, MO |
| David A Perdue , Jr | 37 · PEP, CAT, FDX, GLW, MO, MOS |
| James B. Renacci | 30 · FET, CI, PEP, SPB, ABT, CAT |
| Thomas H Tuberville | 29 · AA, ADM, PEP, FDX, ODFL, ONEQ |
| Thomas R Carper | 27 · PEP, ABT, GLW, MO, MOS, F |
| Kenny Marchant | 25 · AA, ABT, MOS, F, IWM, PFE |
| SUSAN M COLLINS | 24 · PEP, CAT, FDX, DUK, PFE, T |
| K. Michael Conaway | 24 · ADM, PEP, ABT, FDX, MO, F |
| Sheldon Whitehouse | 22 · PEP, ABT, CAT, MO, F, PFE |
| David P. Roe | 22 · PEP, CBRL, F, BP, DUK, PFE |
| Debbie Dingell | 22 · PEP, ABT, CAT, FDX, DUK, PFE |
| Robert J. Wittman | 22 · PEP, ABT, CAT, DUK, PFE, T |